Invention Grant
- Patent Title: Core tablet composite preparation comprising mosapride and rabeprazole
-
Application No.: US16768805Application Date: 2018-11-26
-
Publication No.: US11896718B2Publication Date: 2024-02-13
- Inventor: Byung Jin Kim , Hee Yong Song , Youn Woong Choi , Seong Yeob Kim
- Applicant: KOREA UNITED PHARM. INC.
- Applicant Address: KR Seoul
- Assignee: KOREA UNITED PHARM. INC.
- Current Assignee: KOREA UNITED PHARM. INC.
- Current Assignee Address: KR Seoul
- Priority: KR 20170172473 2017.12.14
- International Application: PCT/KR2018/014610 2018.11.26
- International Announcement: WO2019/117502A 2019.06.20
- Date entered country: 2020-06-01
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/24 ; A61K9/28 ; A61K31/4439 ; A61K31/5375

Abstract:
The present invention relates to a composite preparation in a core tablet form, composed of an inner core containing rabeprazole as an effective ingredient; an outer layer portion including the bilayer structure of a sustained release layer and an immediate release layer and containing mosapride as an effective ingredient. The core tablet composite preparation according to the present invention is characterized by exerting sufficient pharmacological activity of rabeprazole and mosapride even upon administration of one tablet once a day.
Public/Granted literature
- US20210177765A1 CORE TABLET COMPOSITE PREPARATION COMPRISING MOSAPRIDE AND RABEPRAZOLE Public/Granted day:2021-06-17
Information query